Kristin Wald
Women's Health · Saint Louis, MONPI 1871657981
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,404 of the $1,594 with a category attached, or 88.1%. 16 manufacturers reported payments, led by Astellas Pharma US Inc at 24.8% of the total. Reporting peaked in 2023 at $481 and has fallen 56.4% since, to $210 in 2025.
Across 81 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$396
- Organon$220
- AbbVie$212
- Bayer$139
- Exeltis, USA Inc.$103
- Myovant Sciences Inc.$97
- plus $427 from 10 others
What the payments were for
- Food & beverage$1,40488%
- Education$19012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $396 |
| Organon | 17 | $220 |
| AbbVie | 11 | $212 |
| Bayer | 8 | $139 |
| Exeltis, USA Inc. | 6 | $103 |
| Myovant Sciences Inc. | 6 | $97 |
| Mayne Pharma Commercial LLC | 5 | $91 |
| Sumitomo Pharma America, Inc. | 5 | $86 |
| Hologic Sales And Service, LLC | 4 | $81 |
| Pfizer | 3 | $54 |
| Merck | 2 | $31 |
| Coopersurgical, Inc. | 1 | $25 |
| Amgen | 1 | $19 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Avion Pharmaceuticals | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$103
How this compares
$1,594 in reported general payments places this provider in the 75th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $1,980 |
| DottiEstradiol | 13 | $623 |
| Clobetasol Propionate | 11 | $383 |
| Nystatin | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other women's health in Saint Louis
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
- Kris ScalfSaint Louis$7K
- Savannah HayesSaint Louis$6K
- Kelly BallSaint Louis$4K
- Anna BartonSaint Louis$3K
- Amanda MetzSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.